Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita, Y Mashimo… - Cancer chemotherapy …, 2011 - Springer
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

[引用][C] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T HORIMATSU, S MIYAMOTO… - Cancer …, 2011 - pascal-francis.inist.fr
Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6
plus bevacizumab therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita… - Cancer …, 2011 - search.proquest.com
Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6
plus bevacizumab therapy Page 1 SHORT COMMUNICATION Pharmacokinetics of …

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

T Horimatsu, S Miyamoto, S Morita… - Cancer …, 2011 - europepmc.org
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

[引用][C] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita, Y Mashimo… - Cancer Chemotherapy …, 2011 - cir.nii.ac.jp
Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus
bevacizumab therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

[PDF][PDF] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita… - Cancer Chemother …, 2011 - researchgate.net
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

[PDF][PDF] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita… - Cancer Chemother …, 2011 - academia.edu
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy

T Horimatsu, S Miyamoto, S Morita, Y Mashimo… - Cancer Chemotherapy …, 2011 - infona.pl
Purpose To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods A 50-year-old man on chronic …

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

T Horimatsu, S Miyamoto, S Morita… - Cancer …, 2011 - search.ebscohost.com
Purpose: To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus
bevacizumab therapy for a hemodialytic patient. Methods: A 50-year-old man on chronic …